Secernin-1
Secernin-1 (196-204) is a synthetic peptide fragment corresponding to amino acid residues 196 through 204 of the Secernin-1 protein, a cytosolic regulator implicated in vesicle exocytosis and intracellular signaling pathways. As a peptide compound, this fragment enables targeted investigation of Secernin-1's structure-function relationships, offering a focused approach to dissecting the molecular mechanisms underlying its biological activity. The sequence-specific nature of Secernin-1 (196-204) makes it a valuable tool for researchers seeking to explore protein-protein interactions, post-translational modifications, and the role of discrete domains within the full-length protein. Its defined composition and relevance to cellular regulatory processes position it as an important reagent in both basic and applied biochemical research.
Protein interaction studies: Researchers utilize the Secernin-1 (196-204) peptide to probe the specific binding interfaces involved in protein-protein interactions. By introducing this fragment in in vitro assays, scientists can map the interaction sites between Secernin-1 and its known or putative partners, such as those participating in vesicle trafficking or exocytosis. The peptide's defined sequence allows for competition or pull-down experiments to elucidate binding affinities, specificity, and the functional consequences of domain-specific interactions, thereby advancing understanding of the molecular determinants governing Secernin-1-mediated processes.
Epitope mapping and antibody development: The 196-204 region of Secernin-1 serves as a precise epitope for the generation and validation of sequence-specific antibodies. Employing this peptide in immunization protocols or as a reference antigen in ELISA and Western blot applications enables the production of antibodies with high specificity for the target domain. Such antibodies are instrumental in tracking Secernin-1 localization, quantifying expression levels, and distinguishing between different isoforms or post-translationally modified states in complex biological samples.
Phosphorylation and post-translational modification analysis: The defined sequence of Secernin-1 (196-204) provides a tractable substrate for examining potential phosphorylation sites or other post-translational modifications within this key region. By exposing the peptide to relevant kinases or modifying enzymes in vitro, researchers can identify modification patterns, assess site accessibility, and determine the functional impact of such modifications on protein activity. These studies are critical for unraveling regulatory mechanisms that control Secernin-1's role in cellular signaling pathways.
Peptide-based assay development: The Secernin-1 (196-204) fragment is frequently incorporated into custom assay platforms designed to monitor enzyme activity, inhibitor screening, or molecular recognition events. Its defined structure and functional relevance allow for the creation of robust, reproducible assays that facilitate high-throughput screening or mechanistic studies. These peptide-based assays are particularly valuable in the context of drug discovery and basic research, where precise quantification and specificity are paramount.
Structural and conformational studies: The short, sequence-defined nature of Secernin-1 (196-204) makes it amenable to detailed structural analysis using techniques such as NMR spectroscopy or circular dichroism. Researchers employ this peptide to investigate secondary structure propensity, folding dynamics, or conformational changes upon interaction with binding partners or under varying environmental conditions. Insights gained from these studies contribute to a deeper understanding of how discrete domains within Secernin-1 influence its overall function and regulatory capacity within the cell.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.